Juncture Wealth Strategies’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
HCM
FWCM
MSV
AIM
EB
SC
AP
IWA
MPWT
FFA
Juncture Wealth Strategies's ABBV Position: Q3 2026 in Review
Juncture Wealth Strategies increased its AbbVie (ABBV) stake by 451% in Q3 2026, buying an estimated $2.01M and bringing the position to 9,559 shares worth $2.5M. The position accounts for 0.64% of the portfolio, ranked #36.
Juncture Wealth Strategies first reported a position in ABBV in Q3 2025 and has held it in 5 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Juncture Wealth Strategies held 9,559 shares of AbbVie worth $2.5M as of Q3 2026.
- Juncture Wealth Strategies bought 7,824 AbbVie shares in Q3 2026, an estimated $2.01M.
- AbbVie made up 0.64% of Juncture Wealth Strategies's portfolio in Q3 2026, its #36 holding.
- Juncture Wealth Strategies first reported a position in AbbVie in Q3 2025 and has held it in 5 quarters since.
- 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Juncture Wealth Strategies's 13F filing for Q3 2026, filed 6 Oct 2026.